Evidence map›Paper›PMID 33541404›Full record

ArticleClinical epigenetics2021

Changes in epigenetic profiles throughout early childhood and their relationship to the response to pneumococcal vaccination.

Sara Pischedda, Daniel O'Connor, Benjamin P Fairfax, Antonio Salas, Federico Martinon-Torres, Andrew J Pollard, Johannes Trück

Open access · goldAbstract read
In one paragraph

Article in Clinical epigenetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Human genetics of responses to vaccines.Clinical and experimental immunology · 2025
    Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Sara Pischedda *Genetics, Vaccines and Infections and Pediatrics Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago, Santiago de Compostela, Spain. sara.pischedda01@gmail.com.ORCID 0000-0001-6731-2349
Daniel O'Connor *Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and The NIHR Oxford Biomedical Research Centre, Oxford, UK. daniel.oconnor@paediatrics.ox.ac.uk.ORCID 0000-0002-6902-9886
Benjamin P FairfaxMRC-Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.ORCID 0000-0001-7413-5002
Antonio SalasGenetics, Vaccines and Infections and Pediatrics Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago, Santiago de Compostela, Spain.ORCID 0000-0002-2336-702X
Federico Martinon-TorresGenetics, Vaccines and Infections and Pediatrics Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago, Santiago de Compostela, Spain.ORCID 0000-0002-9023-581X
Andrew J PollardOxford Vaccine Group, Department of Paediatrics, University of Oxford, and The NIHR Oxford Biomedical Research Centre, Oxford, UK.ORCID 0000-0001-7361-719X
Johannes TrückOxford Vaccine Group, Department of Paediatrics, University of Oxford, and The NIHR Oxford Biomedical Research Centre, Oxford, UK. johannes.trueck@kispi.uzh.ch.ORCID 0000-0002-0418-7381
University of Oxford · GBComplejo Hospitalario Universitario de Santiago · ESUniversidade de Santiago de Compostela · ES

Funding

Wellcome Trust 201488/Z/16/Z
6 · The paper itself

Abstract

backgroundPneumococcal infections are a major cause of morbidity and mortality in young children and immaturity of the immune system partly underlies poor vaccine responses seen in the young. Emerging evidence suggests a key role for epigenetics in the maturation and regulation of the immune system in health and disease. The study aimed to investigate epigenetic changes in early life and to understand the relationship between the epigenome and antigen-specific antibody responses to pneumococcal vaccination.

methodsThe epigenetic profiles from 24 healthy children were analyzed at 12 months prior to a booster dose of the 13-valent pneumococcal conjugate vaccine (PCV-13), and at 24 months of age, using the Illumina Methylation 450 K assay and assessed for differences over time and between high and low vaccine responders.

resultsOur analysis revealed 721 significantly differentially methylated positions between 12 and 24 months (FDR < 0.01), with significant enrichment in pathways involved in the regulation of cell-cell adhesion and T cell activation. Comparing high and low vaccine responders, we identified differentially methylated CpG sites (P value < 0.01) associated with HLA-DPB1 and IL6.

conclusionThese data imply that epigenetic changes that occur during early childhood may be associated with antigen-specific antibody responses to pneumococcal vaccines.

Indexed as

Antigen-Antibody ReactionsCase-Control StudiesCell CompetitionChild, PreschoolCpG IslandsDNA MethylationEpigenesis, GeneticFemaleHLA-DP beta-ChainsHumansImmune SystemInfantInterleukin-6MalePneumococcal InfectionsPneumococcal Vaccines13-valent pneumococcal vaccineHLA-DPB1 antigenHLA-DP beta-ChainsInterleukin-6Pneumococcal VaccinesTumor Necrosis Factor Receptor Superfamily, Member 7ChildhoodDNA methylationEpigeneticsImmune systemPneumococcal vaccinationVaccine response

Identifiers

PMID33541404
PMCPMC7860179
OpenAlexW3128783720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.